The majority of RTT cases can be attributed to loss-of-function mutations in the X-linked gene MECP2, which encodes the transcriptional regulator methyl-CpG binding protein 2 (MeCP2) (Amir et al., 1999). The gene discussed is MECP2; the disease is Rett syndrome.